Northwestern Mutual Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Buy	10,060 +3,733	+59%	+$119K	﹤0.01%	1713
2026 Q1	$167K	Sell	6,327 -1,502	-19%	-$44K	﹤0.01%	1983
2025 Q4	$227K	Sell	7,829 -582	-7%	-$17.5K	﹤0.01%	1811
2025 Q3	$234K	Sell	8,411 -7,865	-48%	-$199K	﹤0.01%	1737
2025 Q2	$396K	Sell	16,276 -4,653	-22%	-$102K	﹤0.01%	1472
2025 Q1	$434K	Sell	20,929 -13,131	-39%	-$330K	﹤0.01%	1388
2024 Q4	$802K	Sell	34,060 -6,028	-15%	-$148K	﹤0.01%	1142
2024 Q3	$1.03M	Sell	40,088 -126,193	-76%	-$3.21M	﹤0.01%	1055
2024 Q2	$3.9M	Buy	166,281 +3,341	+2%	+$84.3K	﹤0.01%	646
2024 Q1	$4.69M	Sell	162,940 -19,900	-11%	-$598K	﹤0.01%	579
2023 Q4	$6M	Sell	182,840 -19,280	-10%	-$524K	0.01%	497
2023 Q3	$5.63M	Sell	202,120 -6,478	-3%	-$212K	0.01%	483
2023 Q2	$7.11M	Buy	208,598 +6,647	+3%	+$209K	0.01%	437
2023 Q1	$6.07M	Buy	201,951 +5,977	+3%	+$185K	0.01%	444
2022 Q4	$5.53M	Sell	195,974 -8,552	-4%	-$271K	0.01%	444
2022 Q3	$6.72M	Buy	204,526 +3,073	+2%	+$113K	0.01%	359
2022 Q2	$6.34M	Buy	201,453 +23,860	+13%	+$834K	0.01%	369
2022 Q1	$8.16M	Sell	177,593 -31,951	-15%	-$1.52M	0.01%	338
2021 Q4	$12.8M	Sell	209,544 -64,196	-23%	-$4.44M	0.02%	252
2021 Q3	$20.5M	Buy	273,740 +23,984	+10%	+$2.01M	0.04%	190
2021 Q2	$23.1M	Buy	249,756 +48,415	+24%	+$4.12M	0.04%	174
2021 Q1	$17.9M	Buy	201,341 +89,681	+80%	+$8.9M	0.04%	187
2020 Q4	$10.4M	Buy	111,660 +84,469	+311%	+$6.73M	0.02%	227
2020 Q3	$1.73M	Buy	+27,191	New	+$1.59M	﹤0.01%	455
2020 Q2	–	Sell	-4,100	Closed	-$128K	–	2375
2020 Q1	$128K	Buy	+4,100	New	+$137K	﹤0.01%	1027

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Northwestern Mutual Wealth Management's ARKG Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its ARK Genomic Revolution ETF (ARKG) stake by 59% in Q2 2026, buying an estimated $119K and bringing the position to 10,060 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Northwestern Mutual Wealth Management first reported a position in ARKG in Q1 2020 and has held it in 25 quarters since. The position peaked at $23.1M in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Northwestern Mutual Wealth Management held 10,060 shares of ARK Genomic Revolution ETF worth $423K as of Q2 2026.
Northwestern Mutual Wealth Management bought 3,733 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $119K.
ARK Genomic Revolution ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1713 holding.
Northwestern Mutual Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 25 quarters since.
Northwestern Mutual Wealth Management's ARK Genomic Revolution ETF position peaked at $23.1M in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.